1. Home
  2. PTGX vs SID Comparison

PTGX vs SID Comparison

Compare PTGX & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • SID
  • Stock Information
  • Founded
  • PTGX 2006
  • SID 1941
  • Country
  • PTGX United States
  • SID Brazil
  • Employees
  • PTGX N/A
  • SID N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • SID Steel/Iron Ore
  • Sector
  • PTGX Health Care
  • SID Industrials
  • Exchange
  • PTGX Nasdaq
  • SID Nasdaq
  • Market Cap
  • PTGX 2.8B
  • SID 2.7B
  • IPO Year
  • PTGX 2016
  • SID 1997
  • Fundamental
  • Price
  • PTGX $41.65
  • SID $1.97
  • Analyst Decision
  • PTGX Strong Buy
  • SID Sell
  • Analyst Count
  • PTGX 7
  • SID 2
  • Target Price
  • PTGX $53.57
  • SID $2.95
  • AVG Volume (30 Days)
  • PTGX 700.6K
  • SID 2.4M
  • Earning Date
  • PTGX 11-07-2024
  • SID 11-12-2024
  • Dividend Yield
  • PTGX N/A
  • SID 14.95%
  • EPS Growth
  • PTGX N/A
  • SID N/A
  • EPS
  • PTGX 2.68
  • SID N/A
  • Revenue
  • PTGX $323,795,000.00
  • SID $8,019,254,042.00
  • Revenue This Year
  • PTGX $396.93
  • SID N/A
  • Revenue Next Year
  • PTGX N/A
  • SID $1.48
  • P/E Ratio
  • PTGX $15.15
  • SID N/A
  • Revenue Growth
  • PTGX 125.73
  • SID N/A
  • 52 Week Low
  • PTGX $16.80
  • SID $1.82
  • 52 Week High
  • PTGX $48.89
  • SID $4.03
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 41.01
  • SID 44.07
  • Support Level
  • PTGX $33.31
  • SID $1.82
  • Resistance Level
  • PTGX $48.86
  • SID $2.21
  • Average True Range (ATR)
  • PTGX 2.82
  • SID 0.07
  • MACD
  • PTGX -0.62
  • SID 0.00
  • Stochastic Oscillator
  • PTGX 53.63
  • SID 37.18

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. The company operate throughout the entire steel production chain, from the mining of iron ore to the production and sale of a diversified range of steel products. It operates in five segments namely, Steel, Mining, Logistics, Energy, and Cement. It generates maximum revenue from the steel segment. Geographically, it derives a majority of revenue from Asia.

Share on Social Networks: